BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
4/28/17 Radius (RDUS) Tymlos for Osteoporosis / Osteopenia Subscribers Only Subscribers Only Subscribers Only
4/28/17 Takeda (TKPYY) Alunbrig for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
4/28/17 Novartis (NVS) Rydapt for Acute Myelogenous Leukemia (AML) Subscribers Only Subscribers Only Subscribers Only
4/28/17 Johnson & Johnson (JNJ) Darzalex for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
4/28/17 Regeneron (REGN) Kevzara for Rheumatoid Arthritis (RA) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
04/28/17 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
04/29/17 Subscribers Only Subscribers Only Trial Data - Updated Results
04/29/17 Subscribers Only Subscribers Only Trial Data - Updated Results
04/29/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results
04/30/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results